SIEGALL CLAY B bought IMNM
December 18, 2025 · Form 4 insider transaction
SIEGALL CLAY B bought 46,511 shares of Immunome, Inc. at $21.50 per share, a transaction worth $1000.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Acquired (buy-side)
Shares
46,511
Price
$21.50
Total value
$1000.0K
InsiderSIEGALL CLAY B
RoleOfficer, Director
CompanyImmunome, Inc. (IMNM)
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateDecember 18, 2025
Filing dateDecember 18, 2025
Shares owned after853,247
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The Reporting Person purchased the shares in connection with the Issuer's recently completed underwritten public offering of common stock.